EverGlade Insights Blog
New Strategy Leads to New Funding Opportunities for the Development of Medical Countermeasures In the wake of the Coronavirus Disease 2019 (COVID-19) pandemic and a rapidly expanding landscape of biological and chemical threats, the Department...
EverGlade Consulting (“EverGlade”), a national consulting firm, has helped a leading biotechnology company land an award from the Biomedical Advanced Research and Development Authority (BARDA) with a potential $1 billion in federal funding. This multi-year...
President Biden recently launched the administration’s new National Biodefense Strategy and Implementation Plan. The strategy reflects changing dynamics in Washington, especially given the lack of additional funding for COVID. National BiodefenseStrategy and Implementation Summarized The...
EverGlade Consulting (“EverGlade”), a national consulting firm, has successfully partnered with a global leader in mRNA materials used for research, diagnostics, and therapeutics, to successfully manage $39 million in federal funding. The Industrial Base Expansion...
As of August 10, the Center for Disease Control (CDC) reported that over 10,000 cases of monkeypox have been identified in the United States (US). The Biden administration officially declared monkeypox a Public Health Emergency...
With the government fiscal year ending in a few short weeks and Covid continuing to impact the country, new government funding opportunities are plentiful for organizations supporting both the pandemic response and other areas of...